+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation

Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation

Journal of Materials Science. Materials in Medicine 22(4): 865-878

The purpose of this study was to develop sustained release formulation of anastrozole-loaded chitosan microspheres for treatment of breast cancer. Chitosan microspheres cross-linked with two different cross-linking agents viz, tripolyphosphate (TPP) and glutaraldehyde (GA) were prepared using single emulsion (w/o) method. A reverse phase HPLC method was developed and used for quantification of drug in microspheres and rat plasma. Influence of cross-linking agents on the properties of chitosan microspheres was extensively investigated. Formulations were characterized for encapsulation efficiency (EE), compatibility of drug with excipients, particle size, surface morphology, swelling capacity, erosion and drug release profile in phosphate buffer pH 7.4. EE varied from 30.4 ± 1.2 to 69.2 ± 3.2% and mean particle size distribution ranged from 72.5 ± 0.5 to 157.9 ± 1.5 μm. SEM analysis revealed smooth and spherical nature of microspheres. TPP microspheres exhibited higher swelling capacity, percentage erosion and drug release compared to GA microspheres. Release of anastrozole (ANS) was rapid up to 4 h followed by slow release status. FTIR analysis revealed no chemical interaction between drug and polymer. DSC analysis indicated ANS trapped in the microspheres existed in amorphous form in polymer matrix. The highest correlation coefficients (R (2)) were obtained for Higuchi model, suggesting a diffusion controlled mechanism. There was significant difference in the pharmacokinetic parameters (AUC(0-∞), Kel and t(1/2)) when ANS was formulated in the form of microspheres compared to pure drug. This may be attributed to slow release rate of ANS from chitosan microspheres and was detectable in rat plasma up to 48 h which correlates well with the in vitro release data.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056048479

Download citation: RISBibTeXText

PMID: 21431353

DOI: 10.1007/s10856-011-4274-y

Related references

Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study. Aaps Pharmscitech 10(1): 158-165, 2009

Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture. Drug Development and Industrial Pharmacy 43(10): 1703-1714, 2017

Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats. International Journal of Pharmaceutics 338(1-2): 142-151, 2007

Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Die Pharmazie 66(9): 654-661, 2011

Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. European Journal of Pharmaceutics & Biopharmaceutics 53(2): 233-239, 2002

Formulation and in vitro-in vivo evaluation of ketoprofen-loaded albumin microspheres for intramuscular administration. Journal of Microencapsulation 26(5): 456-469, 2009

Docetaxel-loaded chitosan microspheres as a lung targeted drug delivery system: in vitro and in vivo evaluation. International Journal of Molecular Sciences 15(3): 3519-3532, 2014

Systematically Optimized Ketoprofen-Loaded Novel Proniosomal Formulation for Periodontitis: In Vitro Characterization and In Vivo Pharmacodynamic Evaluation. Aaps Pharmscitech 18(5): 1863-1880, 2017

Didanosine-loaded chitosan microspheres optimized by surface-response methodology: a modified "Maximum Likelihood Classification" approach formulation for reverse transcriptase inhibitors. Biomedicine and PharmacoTherapy 70: 46-52, 2015

The sustained-release behavior and in vitro and in vivo transfection of pEGFP-loaded core-shell-structured chitosan-based composite particles. International Journal of Nanomedicine 9: 4965-4978, 2014

Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation. Drug Design Development and Therapy 9: 791-798, 2015

Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation. Archives of Pharmacal Research 34(11): 1919-1929, 2011

Formulation and In Vitro Evaluation of Sustained Release Microspheres of Diltiazem Hydrochloride Prepared by Emulsification-Internal Gelation Method. Journal of Dispersion Science and Technology 31(1): 138-147, 2009

Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation. Journal of Microencapsulation 28(2): 122-133, 2011

Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation. Journal of Pharmacy and Pharmacology 63(2): 169-178, 2011